Nucleic acid detection in pooled samples

• US 20030152942A1
• Filed: 05/09/2002
• Published: 08/14/2003
• Est. Priority Date: 05/09/2001
• Status: Abandoned Application

• Current Assignee: Third Wave Technologies Incorporated (Hologic Incorporated)
• Original Assignee: Third Wave Technologies Incorporated (Hologic Incorporated)
• Inventors: Neri, Bruce P., Fors, Lance, Roeven, Robert, D. Brow, Mary Ann, Indig, Monika de Arruda
• Application Number:
  US10/142,283
• Publication Number:
  US 20030152942A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12Q 1/6823 Release of bound markers
• CPC Class Codes: C12Q 1/6883 for diseases caused by alterations of genetic material
• CPC Class Codes: C12Q 1/703 Viruses associated with AIDS
• CPC Class Codes: C12Q 1/707 non-A, non-B Hepatitis, excluding hepatitis D
• CPC Class Codes: C12Q 2561/109 Invader technology
• CPC Class Codes: C12Q 2600/156 Polymorphic or mutational markers
• CPC Class Codes: G06Q 10/087 Inventory or stock management, e.g. order filling, procurement or balancing against orders
• CPC Class Codes: G06Q 30/06 Buying, selling or leasing transactions

Abstract

The present invention relates to detecting target nucleic acid sequences in pooled samples. In particular, the present invention relates to compositions and methods for detecting the presence or absence of target nucleic acid sequences (e.g. RNA virus sequences) in a pooled sample employing an INVADER detection assay. In certain embodiments, the present invention allows target nucleic acid sequence detection in pooled biological samples (e.g. pooled blood samples) without prior amplification of the target.

Claims

1. A method of performing nucleic acid testing on a pooled sample, comprising:

a) providing;

i) a pooled sample, wherein said pooled sample comprises biological material combined from a plurality of individual samples; and

ii) INVADER assay reagents configured to detect the presence or absence of a target nucleic acid sequence; and

b) contacting said pooled sample with said INVADER assay reagents under conditions such that the presence or absence of said target nucleic acid sequence in said pooled sample is determined.

2. The method of claim 1, wherein said biological material comprises blood.

3. The method of claim 1, wherein said biological material comprises blood plasma.

4. The method of claim 1, wherein said target nucleic acid sequence is RNA.

5. The method of claim 1, wherein said target nucleic acid sequence is DNA.

6. The method of claim 1, wherein said target nucleic acid sequence is from a microorganism.

7. The method of claim 1, wherein said target nucleic acid sequence is from a virus.

8. The method of claim 1, wherein said target nucleic acid sequences is from a pathogen selected from HIV-1, HIV-2, HCV, HBV, HTLVI, HTLV2, and HCMV.

9. The method of claim 1, wherein said target nucleic acid comprises a first and second non-contiguous single-stranded regions separated by an intervening region comprising a double stranded regions, and wherein said INVADER assay reagents comprise;

i) a bridging oligonucleotide capable of binding to said first and second non-contiguous single-stranded regions;

ii) a second oligonucleotide capable of binding to a portion of said first non-contiguous single-stranded region; and

iii) a cleavage means.

10. The method of claim 9, wherein said contacting causes either said second oligonucleotide or said bridging oligonucleotide to be cleaved.

11. The method of claim 1, wherein said plurality of individual samples comprises at least 5 individual samples.

12. The method of claim 1, wherein said plurality of individual samples comprises at least 16 individual samples.

13. The method of claim 1, further comprising, prior to step b), the step of performing polymerase chain reaction on said pooled sample such that said target nucleic acid sequence is amplified if present in said pooled sample.

14. The method of claim 1, wherein said contacting step is performed under conditions such that said target nucleic acid sequence is not amplified before said presence or said absence of said target nucleic acid sequence is determined.

15. A method of performing nucleic acid testing on a pooled sample, comprising:

a) providing;

i) a plurality of individual biological material samples; and

ii) INVADER assay reagents configured to detect the presence or absence of a target nucleic acid sequence; and

b) forming a sub-pool by combining a portion of each of said plurality of individual biological samples, and

c) contacting said sub-pool with said INVADER assay reagents under conditions such that the presence or absence of said target nucleic acid sequence in said sub-pool is determined.

16. The method of claim 15, wherein said contacting indicates that said target nucleic acid sequence is absent from said sub-pool.

17. The method of claim 16, further comprising the step of combining said plurality of individual biological samples into a primary pool.

18. The method of claim 15, wherein said contacting indicates that said target nucleic acid sequence is present in said sub-pool.

19. The method of claim 18, further comprising the step of screening each of said individual biological samples for the presence or absence of said target nucleic acid sequence.

20. A method of performing nucleic acid testing on a pooled sample, comprising:

a) providing;

i) a pooled sample, wherein said pooled sample comprises biological material combined from a plurality of individual samples; and

ii) INVADER assay reagents configured to detect measure the quantity of a target nucleic acid sequence present in a sample; and

b) contacting said pooled sample with said INVADER assay reagents under conditions such that the quantity of said target nucleic acid sequence present in said pooled sample is determined.

21. The method of claim 20, wherein said biological material comprises blood.

22. The method of claim 20, wherein said biological material comprises blood plasma.

23. The method of claim 20, wherein said target nucleic acid sequence is RNA.

24. The method of claim 20, wherein said target nucleic acid sequence is DNA.

25. The method of claim 20, wherein said target nucleic acid sequence is from a microorganism.

26. The method of claim 20, wherein said target nucleic acid sequence is from a virus.

27. A method for detecting an allele frequency of a polymorphism, comprising:

a) providing;

i) a pooled sample, wherein said pooled sample comprises target nucleic acid sequences from a plurality of individuals; and

ii) INVADER assay reagents configured to detect the presence or absence of a polymorphism; and

b) contacting said pooled sample with said INVADER assay reagents to generate a detectable signal; and

c) measuring said detectable signal, thereby determining a number of said target nucleic acid sequences that contain said polymorphism.

28. The method of claim 27, wherein said plurality comprises at least 10 individuals.

29. The method of claim 28, wherein said at least 10 individuals comprises at least 1000 individuals.

30. A method for detecting an allele frequency of a polymorphism, comprising:

a) providing;

i) a pooled sample, wherein said pooled sample comprises target nucleic acid sequences from a plurality of individuals; and

ii) INVADER assay reagents configured to generate distinct signals for each allele of a polymorphic locus in said target nucleic acid sequence;

b) contacting said pooled sample with said INVADER assay reagents to generate at least one distinct signal; and

c) measuring each of said at least one distinct signal, thereby determining a proportion of each allele of said polymorphic locus within said pooled sample.

31. The method of claim 30, wherein said measuring comprises detection of fluorescence.

32. The method of claim 30, wherein at least two distinct signals are generated in step b) and wherein said measuring comprises comparing said at least two distinct signals.

33. The method of claim 32, wherein said comparing comprises applying a correction factor to a measurement of at least one distinct signal.

34. A method for detecting a rare mutation comprising;

a) providing;

i) a sample from a single subject, wherein said sample comprises at least 10,000 target nucleic acid sequences,

ii) a detection assay capable of detecting a mutation in a population of target nucleic acid sequence that is present at an allele frequency of 1;

1000 or less compared to wild type alleles; and

b) assaying said sample with said detection assay under conditions such that the presence or absence of a rare mutation is detected.

35. A method for detecting a rare mutation comprising;

a) providing;

i) a sample from a single subject, wherein said sample comprises at least 10,000 target nucleic acid sequences,

ii) a detection assay capable of detecting a mutation in a population of target nucleic acid sequence that is present at an allele frequency of 1;

1000 or less compared to wild type alleles; and

b) assaying said sample with said detection assay under conditions such that an allele frequency in said sample of a rare mutation is determined.